Dr Kolberg Provides A Global Perspective On Biosimilar Integration | Latest News RSS feed

Dr Kolberg Provides A Global Perspective On Biosimilar Integration - Latest News


Roche Holding's (RHHBY) CEO Dr. Severin Schwan on Q1 2017 Results - Earnings Call Transcript

Roche Holding Ltd. (ADR) (OTCQX:RHHBY) Q1 2017 Results Earnings Conference Call April 27, 2017 8:00 AM ET Executives Dr. Severin Schwan - CEO Daniel ... with some of our major brands facing up coming ... read more

Clinical trials insight: oncology

How have cancer biosimilars programmes affected global clinical trials ... However, in Eastern Europe or Latin America, a biosimilars trial may provide access to drugs that, while approved, are not ye... read more

Johnson & Johnson CEO Discusses Q4 2013 Results - Earnings Call Transcript

Johnson & Johnson (JNJ) Q4 2013 Results Earnings Call January 21 ... we believe provide us with a great opportunity to update you on our progress, as well as our plans and our perspectives about how w... read more

Looking for another news?


Global API industry entering a new growth phase

Advancements in the production technology have enabled production of biosimilars ... such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the lea... read more


Premier (North Carolina) (PINC) Q1 2019 Results - Earnings Call Transcript

Susan, Mike, and Craig will review the quarter's performance, provide an operations ... from our members' perspective, they know this is coming. They know CMS wants a more global payment model ... read more

Global Network Week: A model for multicultural teams

Social Integration is Critical: But how can it be achieved? In one of the influential review papers on multicultural teams, published in 2009, Dr.Günter Stahl ... member schools of the Global Network ... read more

Global Health Perspective in Sarcomas and Other Rare Cancers

Physicians need a global perspective on access to old and novel high-cost medications.An integrated approach including physicians, industry, and policy makers is required for effective management of s... read more

Amgen's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Hooper - Executive Vice President of Global Commercial Operations Sean E ... Kevin is with us this afternoon, but before I turn the call over to him, I will just provide our customary reminders. We wi... read more

Dr. Reddy's Laboratories Announces the Launch of Atomoxetine Capsules, USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Atomoxetine Capsules, USP, a thera... read more

How Boundary Spanners Create Profits From Conflict

Despite increasing conflict potential and frequency, conflict today is not necessarily regarded as dysfunctional or the result of inefficient global integration ... Boundary spanners provide solutions ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us